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Nutritional supplements in cystic fibrosis
A new study suggests they’re ineffective, but concordance may have been poor
People with cystic fibrosis and their caregiversknow that the better the patient’s nutritionalstatus, the better their survival, lung function,
wellbeing, and mental capabilities.1–3 Poor nutrition is
also associated with delayed puberty, a higher risk of
pneumothorax, and a worse outcome after lung
transplantation.4 5
The increased demand for energy in cystic fibrosis
is well recognised.6 Despite this, almost 20% of children
with cystic fibrosis fall below the fifth centile for weight
set by the Centers for Disease Control and Prevention,7
and their height and weight z scores often decline with
age. Combating nutritional failure to ensure normal
growth and weight gain is therefore a key challenge for
the entire team—doctors, nurses, dietitians, psycholo-
gists, and social workers.
Nutritional management in cystic fibrosis is
difficult for several medical and psychosocial reasons.
One priority is the optimal medical management of
malabsorption from exocrine pancreatic insufficiency
and deranged enterohepatic circulation of bile.
Patients continuously have to adjust the dose of exo-
genous pancreatic enzymes they need to take to allow
assimilation of ingested food. Meanwhile, patients
often need lung clearance techniques and antibiotic
treatments to reduce the increased energy demand
from chronic pulmonary infection and inflammation
and breathing difficulties. These toddlers, children,
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adolescents, and adults have to integrate into “normal”
life this huge burden of lifelong daily treatment.
Mealtimes can be psychological battlefields for
such families, with eating often reflecting a child’s first
experience of power struggles. Difficulties may recur in
puberty, an age that may be critical for the further
course of the disease; they are often exacerbated by the
need for patients to conform to today’s ideal that “thin
is beautiful.” Just as treating patients with anorexia
nervosa needs more than simply prescribing supple-
ments, efforts to clarify the underlying psychodynamic
processes in cystic fibrosis may be critical for success.
In this issue (p 632) Poustie and colleagues present
an important, well planned, and carefully conducted
randomised multicentre study of oral supplements in
cystic fibrosis patients.8 Concordance with the inter-
vention was reinforced continuously by staff making
regular home visits. Nevertheless, the prescription of
extra oral supplements failed to improve the
nutritional status of the patients.
The trial was conducted to detect a 10 point
difference in centile for bodymass index within one year
of the intervention, comparing patients receiving dietary
advice with patients who were also prescribed oral
energy supplements. This means that the trial was pow-
ered to detect, for example, a difference in weight gain of
2 kg between two 9 year old girls allocated to the differ-
ent treatment groups. This was a noble goal, but an over-
optimistic end point for a clinical trial in cystic fibrosis.
The authors say that the intervention failed
because of inconsistency or inaccuracy in the dietary
records and, perhaps, because patients did not take the
supplements they were prescribed. In addition, the
appropriately used statistical method, intention to treat
analysis, may have led to underestimation of the effects
of the intervention, but a per protocol analysis was not
possible in this trial because adherence to treatment
was unknown. Therefore conclusions from the trial
must be drawn very carefully.
Treatments for cystic fibrosis are time consuming,
generally unpleasant, and potentially anxiety provok-
ing, and this can be particularly problematic when
patients are feeling generally healthy. Professionals
often have to “sell” such medical options to patients.
Powers and colleagues have reported how they
successfully influenced the behavioural aspects of
nutrition in children with cystic fibrosis by using a
multidisciplinary approach.9 The “intention to feed” is
certainly not enough.
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